Hinge Health, Inc. Class A ( (HNGE) ) has released its Q2 earnings. Here is a breakdown of the information Hinge Health, Inc. Class A presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Hinge Health, Inc. is a San Francisco-based company specializing in the delivery of healthcare solutions for musculoskeletal conditions through an AI-powered platform, combining wearable devices and expert clinician access to provide personalized care.
In its second quarter of 2025, Hinge Health reported a substantial 55% increase in revenue compared to the same period in 2024, reaching $139.1 million. This growth underscores the market’s positive reception of its AI-driven healthcare platform, despite challenges in automating healthcare delivery.
Key financial highlights include a GAAP gross margin of 70% and a non-GAAP gross margin of 83%, with a notable increase in non-GAAP income from operations to $26.1 million from a loss of $14.4 million in the previous year. The company also saw a 32% increase in its client base, now totaling 2,359 clients. However, the GAAP loss from operations was significant at $580.7 million, largely due to stock-based compensation expenses.
Looking ahead, Hinge Health anticipates continued revenue growth, projecting between $141 million and $143 million for Q3 2025, and expects to achieve a non-GAAP income from operations of $17 million to $21 million. For the full fiscal year, the company forecasts revenue between $548 million and $552 million, reflecting a 41% year-over-year growth at the midpoint.
With a strong cash position of $415.1 million and a strategic focus on expanding its AI-powered healthcare solutions, Hinge Health is well-positioned to capitalize on future growth opportunities in the healthcare sector.